India's bio economy has experienced remarkable growth, skyrocketing from US $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
Both the products are Gadolinium based Magnetic Resonance Imaging (MRI) contrast agents and will be the first set of contrast agent products in Zydus’ injectable portfolio for the US market
The USFDA inspection focused on evaluating the facility's adherence to global regulatory requirements and best practices
The acquisition is based on an enterprise value of Rs. 1,660 crore
Coal India has committed to providing upto Rs. 3 crore to treat thalassaemia and aplastic anaemia patients for a period of 3 years
Transform healthcare by integrating expertise from AI, clinical sciences, and basic sciences to harness India’s extensive data sets for improving the access to healthcare
Chobhe brings over 30 years of extensive experience in quality and regulatory management within the pharmaceutical industry
Effective, holistic, science-backed targeted solutions for symptomatic treatment
Vonoprazan is used in the treatment of disorders related to Gastroesophageal Reflux Disease (GERD)
The company will take all necessary steps to work with USFDA towards earliest remediation of the above facility
Subscribe To Our Newsletter & Stay Updated
